SR One, the corporate venture capital arm of GlaxoSmithKline, has led a $30m funding round for London-based biotechnology company Pulmocide.
Transaction will allow 72 stores to continue to operate as normal, saving 800 jobs in the process
Ardian will continue its strategy of external growth in the European food industry through the acquisition
Heikki Westerlund had taken up his position in 2013 and will stay on until a replacement is appointed
GP sold around 70% of the UK-based teleradiology business after a four-year tenure